VHL SYNDROME
Clinical trials for VHL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new VHL SYNDROME trials appear
Sign up with your email to follow new studies for VHL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shrinks kidney tumors in rare genetic disease
Disease control OngoingThis study tests a drug called belzutifan for people with von Hippel-Lindau (VHL) disease who have kidney cancer. The goal is to see if the drug can shrink kidney tumors and avoid surgery. About 50 adults with VHL and at least one measurable kidney tumor will take the pill and be…
Matched conditions: VHL SYNDROME
Phase: PHASE2 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
Scientists dive deep into kidney cancer diversity in rare genetic condition
Knowledge-focused OngoingThis study looks at kidney tumors in people with von Hippel-Lindau (VHL) syndrome, a rare genetic condition that raises the risk of several cancers. Researchers will use advanced imaging and genetic tests to understand why each tumor is different. The goal is to learn more about …
Matched conditions: VHL SYNDROME
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 07, 2026 19:47 UTC